SGLT2 INHIBITORS IN KIDNEY TRANSPLANTATION: A MULTICENTER STUDY

被引：0
|
作者：
Garcia Carro, Clara [1 ]
Bedia Raba, Andrea [2 ]
Banegas Deras, Eduardo J. [3 ]
Alberto Vigara, Luis [4 ]
Valero San Cecilio, Rosalia [5 ]
Cruzado Vega, Leonidas [6 ]
Gavela, Eva [7 ]
Gonzalez Garcia, M. Elena [7 ]
Perez-Flores, Isabel [1 ]
Sanchez-Bielsa, Francisco [1 ]
机构：
[1] San Carlos Clin Univ Hosp, Nephrol Dept, Madrid, Spain
[2] Cruces Hosp, Nephrol Dept, Bilbao, Spain
[3] Hosp Cent Asturias, Nephrol Dept, Olviedo, Spain
[4] Hosp Univ Puerta Mar, Cadiz, Spain
[5] Valdecilla Hosp, Nephrol Dept, Santander, Spain
[6] Dr Peset Hosp, Nephrol Dept, Valencia, Spain
[7] La Paz Univ Hosp, Nephrol Dept, Madrid, Spain
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2022年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
FC 116
引用
收藏
页码：I884 / I884
页数：1
相关论文
共 50 条
  • [21] SGLT2 Inhibitors and Kidney Outcomes in Patients with Chronic Kidney Disease
    Kanduri, Swetha R.
    Kovvuru, Karthik
    Hansrivijit, Panupong
    Thongprayoon, Charat
    Vallabhajosyula, Saraschandra
    Pivovarova, Aleksandra I.
    Chewcharat, Api
    Garla, Vishnu
    Medaura, Juan
    Cheungpasitporn, Wisit
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (09)
  • [22] SGLT2 Inhibitors slow the Progression of chronic Kidney Disease
    不详
    DIABETOLOGE, 2019, 15 (06): : 567 - 567
  • [23] Are SGLT2 inhibitors a targeted treatment for diabetic kidney disease?
    Kanda, Eiichiro
    Nangaku, Masaomi
    KIDNEY INTERNATIONAL, 2019, 96 (01) : 8 - 10
  • [24] Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors
    DeFronzo, Ralph A.
    Reeves, W. Brian
    Awad, Alaa S.
    NATURE REVIEWS NEPHROLOGY, 2021, 17 (05) : 319 - 334
  • [25] Systematic review: SGLT2 inhibitors and acute kidney injury
    Reactions Weekly, 2019, 1784 (1) : 12 - 12
  • [26] Expanding the Impact of SGLT2 Inhibitors in Chronic Kidney Disease
    Makawi, Alaa T.
    Tawfik, Yahya M. K.
    Dixon, Dave L.
    McMahon, Gearoid M.
    Buckley, Leo F.
    AMERICAN JOURNAL OF NEPHROLOGY, 2024, 55 (04) : 417 - 420
  • [27] Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors
    Ralph A. DeFronzo
    W. Brian Reeves
    Alaa S. Awad
    Nature Reviews Nephrology, 2021, 17 : 319 - 334
  • [28] Combination therapy with SGLT2 inhibitors for diabetic kidney disease
    Cai, Yuwen
    Liu, Xin
    Xu, Gaosi
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 127
  • [29] The kidney as a new target for antidiabetic drugs: SGLT2 inhibitors
    Cangoz, S.
    Chang, Y. -Y.
    Chempakaseril, S. J.
    Guduru, R. C.
    Huynh, L. M.
    John, J. S.
    John, S. T.
    Joseph, M. E.
    Judge, R.
    Kimmey, R.
    Kudratov, K.
    Lee, P. J.
    Madhani, I. C.
    Shim, P. J.
    Singh, S.
    Singh, S.
    Ruchalski, C.
    Raffa, R. B.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2013, 38 (05) : 350 - 359
  • [30] SGLT2 Inhibitors in Kidney Diseases-A Narrative Review
    Gajewska, Agata
    Wasiak, Jakub
    Sapeda, Natalia
    Mlynarska, Ewelina
    Rysz, Jacek
    Franczyk, Beata
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (09)
12345